Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1997-1-30
|
pubmed:abstractText |
Fluorescence in situ hybridization in combination with morphology (MGG/FISH) was used to detect minimal residual disease (MRD) in complete remission (CR) in 12 cases of acute leukaemia (six MDS-AML, five de novo AML, one pre-B ALL) with numerical chromosomal aberrations at diagnosis. Residual leukaemic cells could be detected in the remission bone marrows by MGG/FISH in five patients, whereas the other seven showed no abnormalities. All five patients with signs of MRD at CR relapsed in the bone marrow with 2-9 months, in contrast to two of seven with a normal finding by MGG/FISH at CR. In both these patients a second MGG/FISH analysis showed that a subpopulation of leukaemic blasts had reappeared, 4 and 5 months prior to the leukaemia becoming clinically overt. One patient suffered a CNS relapse, but without any evidence of bone marrow involvement. The remaining four patients with no evidence of MRD at CR were still in haematological remission at follow-up after 4, 11, 12 and 13 months, respectively. We conclude that MGG/FISH seems to be a clinically useful method to detect MRD in acute leukaemia and to predict relapses, particularly when repeat studies are performed during CR.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0007-1048
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
95
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
666-72
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8982043-Adult,
pubmed-meshheading:8982043-Aged,
pubmed-meshheading:8982043-Chromosome Aberrations,
pubmed-meshheading:8982043-Female,
pubmed-meshheading:8982043-Follow-Up Studies,
pubmed-meshheading:8982043-Humans,
pubmed-meshheading:8982043-In Situ Hybridization, Fluorescence,
pubmed-meshheading:8982043-Interphase,
pubmed-meshheading:8982043-Karyotyping,
pubmed-meshheading:8982043-Leukemia, Myeloid,
pubmed-meshheading:8982043-Male,
pubmed-meshheading:8982043-Metaphase,
pubmed-meshheading:8982043-Middle Aged,
pubmed-meshheading:8982043-Neoplasm, Residual,
pubmed-meshheading:8982043-Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:8982043-Prognosis,
pubmed-meshheading:8982043-Recurrence
|
pubmed:year |
1996
|
pubmed:articleTitle |
Fluorescence in situ hybridization in combination with morphology detects minimal residual disease in remission and heralds relapse in acute leukaemia.
|
pubmed:affiliation |
Department of Medicine, Karolinska Institute, Danderyd Hospital, Stockholm, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|